Interesting facts
(14S,27R)-22,33-dimethoxy-13,28-dimethyl-2,5,7,20-tetraoxa-13,28-diazaoctacyclo[25.6.2.216,19.13,10.121,25.04,8.031,35.014,39]nonatriaconta-1(33),3(39),4(8),9,16(38),17,19(37),21,23,25(36),31,34-dodecaene
This complex compound is a fascinating example of the intricacies found within organic chemistry. Its multi-cyclic structure consists of various functional groups that contribute to its unique properties. Here are some interesting facts:
- Stereochemistry: The designation of (14S,27R) indicates chiral centers, showcasing the compound's potential for stereoisomerism, which can significantly affect its biological activity and reactivity.
- Complexity: Featuring a total of 28 individual atoms in its core structure, this compound illustrates the remarkable diversity of organic compounds. Its tetraoxa and diaza moieties play crucial roles in bonding and interactions.
- Functional Potential: The presence of methoxy groups suggests possible applications in medicinal chemistry, as such substituents often enhance solubility and bioactivity in drug design.
- Applications: Given its complex structure, this compound could be investigated for potential uses in fields like pharmaceuticals, materials science, and agricultural chemistry.
- Research Opportunity: Innovations in synthetic methods may be necessary to produce this compound efficiently, making it an exciting target for organic synthesis research.
This compound exemplifies the fusion of chemistry and creativity, reminding us that even the most intricate structures can yield profound discoveries. Its study highlights the importance of understanding structural relationships in chemical compounds, paving the way for new breakthroughs in various scientific domains.
Synonyms
CEPHARANTHINE
(+)-Cepharanthine
O-Methylcepharanoline
Cepharantin
Cepharanthine [JAN]
CCRIS 6539
6',12'-Dimethoxy-2,2'-dimethyl-6,7-(methylenebis(oxy))oxyacanthan
Cepharanthine (TN)
NSC 623442
NSC-623442
UNII-7592YJ0J6T
BRN 0075231
CHEBI:3546
Cepharanthine (JAN)
DTXSID6045957
7592YJ0J6T
(14S,27R)-22,33-dimethoxy-13,28-dimethyl-2,5,7,20-tetraoxa-13,28-diazaoctacyclo[25.6.2.216,19.13,10.121,25.04,8.031,35.014,39]nonatriaconta-1(33),3(39),4(8),9,16(38),17,19(37),21,23,25(36),31,34-dodecaene
CEPHARANTHINE [MI]
CEPHARANTHINE [WHO-DD]
DTXCID4025957
4-27-00-09061 (Beilstein Handbook Reference)
Oxyacanthan, 6',12'-dimethoxy-2,2'-dimethyl-6,7-(methylenebis(oxy))-
(14S,27R)-22,33-dimethoxy-13,28-dimethyl-2,5,7,20-tetraoxa-13,28-diazaoctacyclo[25.6.2.2(16,19).1(3,10).1(21,25).0(4,8).0(14,39).0(31,35)]nonatriaconta-1(33),3,8,10(39),16,18,21(36),22,24,31,34,37-dodecaene
(14S,27R)-22,33-dimethoxy-13,28-dimethyl-2,5,7,20-tetraoxa-13,28-diazaoctacyclo(25.6.2.2(16,19).1(3,10).1(21,25).0(4,8).0(14,39).0(31,35))nonatriaconta-1(33),3,8,10(39),16,18,21(36),22,24,31,34,37-dodecaene
(14S,27R)-22,33-dimethoxy-13,28-dimethyl-2,5,7,20-tetraoxa-13,28-diazaoctacyclo(25.6.2.216,19.13,10.121,25.04,8.031,35.014,39)nonatriaconta-1(33),3(39),4(8),9,16(38),17,19(37),21,23,25(36),31,34-dodecaene
Oxyacanthan, 6',12'-dimethoxy-2,2'-dimethyl-6,7-(methylenebis(oxy))-(9CI)
481-49-2
Cepharanthin
NSC623442
ecaene (non-preferred name)
22,33-Dimethoxy-13,28-dimethyl-2,5,7,20-tetraoxa-13,28-diazaoctacyclo[25.6.2.216,19.13,10.121,25.04,8.031,35.014,39]nonatriaconta-1(33),3(39),4(8),9,16(38),17,19(37),21,23,25(36),31,34-dodecaene
CAS-481-49-2
SR-01000779734
NCGC00095194-01
(14S,27R)-22,33-dimethoxy-13,28-dimethyl-2,5,7,20-tetraoxa-13,28-diazaoctacyclo[25.6.2.2~16,19~.1~3,10~.1~21,25~.0~4,8~.0~14,39~.0~31,35~]nonatriaconta-1(33),3,8,10(39),16,18,21(36),22,24,31,34,37-dod
Ex Cepharantha tuber
MFCD00210482
Cepharanthine (Standard)
Spectrum2_000832
Spectrum3_001963
UPCMLD-DP054
BSPBio_003563
MLS000728518
SCHEMBL154545
SPECTRUM1505322
SPBio_000783
CHEMBL449782
UPCMLD-DP054:001
HY-N6972R
KBio3_002909
Cepharanthine, >=95% (HPLC)
Cepharanthine, >=98% (HPLC)
HMS1922J12
HMS2232F21
Pharmakon1600-01505322
HY-N6972
Tox21_111483
BBL030154
BDBM50423643
CCG-40294
NSC758965
s4238
STK801907
AKOS004119865
Tox21_111483_1
FC66045
NSC-758965
SDCCGMLS-0066893.P001
NCGC00161621-01
NCGC00161621-02
NCGC00161621-03
NCGC00161621-05
NCGC00161621-13
AC-15206
AS-17451
DA-51781
SMR000445632
SBI-0207049.P001
CS-0007138
M2968
C09391
D01035
AB00643356_08
AB00643356_09
SR-01000779734-3
SR-01000779734-4
BRD-K96194081-001-06-0
BRD-K96194081-001-10-2
BRD-K96194081-001-11-0
Q15410888
6',12'-Dimethoxy-2,2'-dimethyl-6,7-[methylenebis-(oxy)]oxyacanthan
(14S,27R)-22,33-DIMETHOXY-13,28-DIMETHYL-2,5,7,20-TETRAOXA-13,28-DIAZAOCTACYCLO[25.6.2.2(1)?,(1)?.1(3),(1)?.1(2)(1),(2)?.0?,?.0(3)(1),(3)?.0(1)?,(3)?]NONATRIACONTA-1(34),3(39),4(8),9,16,18,21(36),22,24,31(35),32,37-DODECAENE
(14S,27R)-22,33-dimethoxy-13,28-dimethyl-2,5,7,20-tetraoxa-13,28-diazaoctacyclo[25.6.2.2??,??.1?,??.1??,??.0?,?.0??,??.0??,??]nonatriaconta-1(33),3,8,10(39),16,18,21(36),22,24,31,34,37-dodecaene
Solubility of (14S,27R)-22,33-dimethoxy-13,28-dimethyl-2,5,7,20-tetraoxa-13,28-diazaoctacyclo[25.6.2.216,19.13,10.121,25.04,8.031,35.014,39]nonatriaconta-1(33),3(39),4(8),9,16(38),17,19(37),21,23,25(36),31,34-dodecaene
The solubility of complex organic compounds, such as (14S,27R)-22,33-dimethoxy-13,28-dimethyl-2,5,7,20-tetraoxa-13,28-diazaoctacyclo[25.6.2.216,19.13,10.121,25.04,8.031,35.014,39]nonatriaconta-1(33),3(39),4(8),9,16(38),17,19(37),21,23,25(36),31,34-dodecaene, can be influenced by several factors. This particular compound, characterized by its multi-cyclic structure and presence of numerous functional groups, often demonstrates varied solubility based on the solvent used.
In general, complex compounds like this may be solvents sensitive, meaning they would have improved solubility in some solvents over others. As a result, experimentation in various solvents and conditions is essential in determining its practicality in applications where solubility is key. Therefore, it's often recommended to explore different solvents through systematic trials and observe the visual changes, as solubility data can significantly impact methodological approaches in various scientific disciplines.